Alan Mendelsohn

Insider Reports History

Location
Woodcliff Lake, NJ
Signature
/s/ Joseph Lucchese, Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alan Mendelsohn:

Company Role Class Num Shares Value Price $ Report Date Ownership
Timber Pharmaceuticals, Inc. EVP & CMO Common Stock, par value $0.001 per share 35,393 $57,655 $1.63 20 Aug 2023 Direct
Timber Pharmaceuticals, Inc. EVP & CMO Common Stock, par value $0.001 per share 39 $64 $1.63 20 Aug 2023 By spouse
Timber Pharmaceuticals, Inc. EVP & CMO Stock Option (right to buy) 22,505 15 Apr 2023 Direct

Insider Reports Filed by Alan Mendelsohn

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000143774923024470-mendelsohn-alan-2023-08-20 Timber Pharmaceuticals, Inc. 20 Aug 2023 1 $0 4 EVP & CMO 22 Aug 2023, 20:45
/report/000143774923010519-mendelsohn-alan-2023-04-15 Timber Pharmaceuticals, Inc. 15 Apr 2023 1 $0 4 EVP & CMO 18 Apr 2023, 11:40
/report/000110465922047221-mendelsohn-alan-2022-04-15 Timber Pharmaceuticals, Inc. 15 Apr 2022 1 $0 4 Chief Medical Officer 19 Apr 2022, 13:02
/report/000090571821001534-mendelsohn-alan-2021-11-23 Timber Pharmaceuticals, Inc. 23 Nov 2021 1 +$4,700 4 Chief Medical Officer 24 Nov 2021, 15:11
/report/000110465921089397-mendelsohn-alan-2021-07-01 Timber Pharmaceuticals, Inc. 01 Jul 2021 1 $0 4 Chief Medical Officer 06 Jul 2021, 16:06
/report/000090571821000665-mendelsohn-alan-2021-03-03 Timber Pharmaceuticals, Inc. 03 Mar 2021 1 +$4,314 4 Chief Medical Officer 13 May 2021, 16:06